Worth up to 11.0 credits!
Available Credits: ACPE-P/T, AMA, ANCC, APA, ASWB, CCMC and Attendance
Start Date: July 16, 2021
Expiration Date: July 16, 2023
These activities are designed to meet the educational needs of case managers, nurses, pharmacists, pharmacy technicians, physicians and other health care professionals who are interested in the care and management of oncology, solid organ and blood/marrow transplantation patient populations.
This activity consists of recorded presentations from "Essentials of Oncology, Solid Organ and Blood/Marrow Transplant Management for the Health Care Team" held virtually May 5–6, 2021. Throughout these activities, faculty will discuss the keys to optimize the management/benefits of individuals with cancer and/or undergoing organ or blood/marrow transplant. Participants will hear about current topics and exciting advances in the fields of transplantation and oncology, as well as learning about specific transplanted organs, recent trends in immunosuppression management, gene therapy, and drug development.
At the end of these educational activities, participants should be able to:
- Recognize therapeutic options in cancer treatments to include immunotherapy for lung cancer.
- Evaluate transplantation with low-listing MELD scores.
- Provide an update on current management therapies for acute and chronic graft-versus-host disease (GVHD) and infectious complications after chimeric antigen receptor (CAR) T-cell therapy.
- Detail the benefits of a combined procedure of liver transplantation and heart surgery.
- Examine the effects of the COVID-19 pandemic on cancer care.
- Describe the role of frailty in risk assessment and the effects on outcomes and recovery after transplantation.
- Explain the current heart transplant allocation policy and best collaborative practices to increase organ donation.
- Analyze emerging strategies to predict, induce and monitor graft tolerance in kidney transplantation.
- Explore the current medical and surgical techniques for managing intestinal failure.
- Discuss the role of CRISPR/Cas9, its application and potential for treating human disease.
Click on the activity title for more information or to view.
|Update on GVHD Therapies: Acute and Chronic|
Amin M. Alousi, MD,
Professor, Department of Stem Cell Transplantation
Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center
|CRISPR Technology and the Potential Applications for Treating Diseases|
John F. DiPersio, MD, PhD
Virginia E and Samuel J Golman Professor of Medicine
Chief, Division of Oncology
Director, Center for Gene and Cellular Immunotherapy
Deputy Director, Siteman Cancer Center
Washington University School of Medicine
St. Louis, MO
|Transplantation with Low-Listing MELD Scores|
R. Mark Ghobrial, MD, PhD, FACS, FRCS(Ed)
J.C. Walter Jr. Presidential Distinguished Chair
Director, J.C. Walter Jr. Transplant Center
Professor of Surgery, Academic Institute
Full Member, Research Institute
Weill Cornell Medical College
|Growing Challenges in Heart Transplantation|
Radha Gopalan, MD, FACC
Medical Director, Advanced Heart Failure, Mechanical Circulatory
Support, and Transplant
|Infectious Complications After CAR T-cell Therapy|
Joshua A. Hill, MD
Assistant Professor, Vaccine and Infectious Disease Division
Fred Hutchinson Cancer Research Center;
Assistant Professor, Department of Medicine
Division of Allergy and Infectious Diseases
University of Washington
Frailty in Transplantation
Michael Petty, PhD, RN, APRN-CNS
|New Therapies for Acute Myeloid Leukemia|
Nandita Khera, MD, MPH
Consultant, Division of Hematology/Oncology
|Immunotherapy for the Treatment of Lung Cancer|
Amit Kulkarni, MBBS
Assistant Professor of Medicine
Division of Hematology, Oncology and Transplantation
University of Minnesota
|Predicting, Inducing and Monitoring Graft Tolerance in Kidney Transplantation|
Joseph R. Leventhal, MD, PhD
Interim Chief of Organ Transplantation, Department of Surgery
Fowler McCormick Professor of Surgery
Professor of Surgery (Organ Transplantation)
|Current Approaches to Intestinal Failure|
David F. Mercer, MD, PhD, FRCS(C), FACS
Professor, Department of Surgery
Division of Transplantation
Director, Intestinal Rehabilitation
University of Nebraska Medical Center
|The Effects of COVID-19 on Cancer Care|
Diane Reidy-Lagunes, MD, MS
Associate Deputy Physician-in-Chief, Regional Care Network
President of the Medical Staff
Memorial Sloan Kettering Cancer Center
New York, NY
|Cardiac Surgery in Patients with End-Stage Liver Disease|
Rodrigo Martinez de Mello Vianna, MD, PhD
Director of Solid Organ Transplant Services
Professor and Chief, Liver and Gastrointestinal Transplantation
The Andreas Tzakis Chair in Transplant Surgery
Department of Surgery
University of Miami/Jackson Memorial Hospital;
Miami Transplant Institute
Method of Participation
There are no fees for participating in or receiving credit for this activity.
For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.
Participants will receive a certificate upon successful completion of the activity, which includes the following:
- Completing the entire activity
- Completing the Pre- and Post-Activity Assessment, Activity Evaluation, and Application for Certificate of Credit forms
You must be logged into your account to participate in this activity. Get started by clicking “Continue” and completing the “Pre-Activity Assessment”; then follow the prompts at the bottom of the screen. At the end of the activity, you will be able to view, save or print your certificate of participation. A complete listing of all of your activities can be found under “My Account”, “My Activities.”
These activities are provided by OptumHealth Education.
There was no commercial support provided for these activities.
Please ensure you are using the web-browser Chrome and disable any pop-up blocking software. Click here for information on how to enable pop-ups.